Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study

被引：0
作者：
Stefano Tancredi
Arnaud Chiolero
Cornelia Wagner
Moa Lina Haller
Patricia Chocano-Bedoya
Natalia Ortega
Nicolas Rodondi
Laurent Kaufmann
Elsa Lorthe
Hélène Baysson
Silvia Stringhini
Gisela Michel
Chantal Lüdi
Erika Harju
Irene Frank
Medea Imboden
Melissa Witzig
Dirk Keidel
Nicole Probst-Hensch
Rebecca Amati
Emiliano Albanese
Laurie Corna
Luca Crivelli
Julia Vincentini
Semira Gonseth Nusslé
Murielle Bochud
Valérie D’Acremont
Philipp Kohler
Christian R. Kahlert
Alexia Cusini
Anja Frei
Milo A. Puhan
Marco Geigges
Marco Kaufmann
Jan Fehr
Stéphane Cullati
机构：
[1] University of Fribourg,Population Health Laboratory (#PopHealthLab)
[2] McGill University,School of Population and Global Health
[3] University of Bern,Institute of Primary Health Care (BIHAM)
[4] Bern University Hospital,Department of General Internal Medicine, Inselspital
[5] University of Bern,Unit of Population Epidemiology, Division of Primary Care Medicine
[6] Cantonal Public Health Service of the Canton of Neuchâtel,Department of Health and Community Medicine, Faculty of Medicine
[7] Geneva University Hospitals,University Center for General Medicine and Public Health
[8] University of Geneva,Department Health Sciences and Medicine
[9] University of Lausanne,Clinical Trial Unit
[10] University of Lucerne,Institute of Public Health, Faculty of Biomedical Sciences
[11] Lucerne Cantonal Hospital,Department of Business Economics, Health and Social Care
[12] Swiss Tropical and Public Health Institute,Center for Primary Care and Public Health (Unisanté)
[13] University of Basel,Division of Infectious Diseases and Hospital Epidemiology
[14] Università Della Svizzera Italiana,Department of Infectious Diseases and Hospital Epidemiology
[15] University of Applied Sciences and Arts of Southern Switzerland,Division of Infectious Diseases
[16] University of Lausanne,Epidemiology, Biostatistics and Prevention Institute
[17] Cantonal Hospital St Gallen,Department of Readaptation and Geriatrics
[18] Children’s Hospital of Eastern Switzerland,undefined
[19] Cantonal Hospital of Grisons,undefined
[20] University of Zurich,undefined
[21] University of Geneva,undefined
来源：
Infection | 2023年 / 51卷
关键词：
COVID-19 pandemic; SARS-CoV-2; Seroprevalence; Epidemiology; Public health; Surveillance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1453 / 1465
页数：12
相关论文
共 149 条
[1]  
Byambasuren O(2021)Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: systematic review PLoS One 16 1437-1438
[2]  
Dobler CC(2021)Magnitude of asymptomatic COVID-19 cases throughout the course of infection: a systematic review and meta-analysis PLoS One 16 1762-1771
[3]  
Bell K(2020)Diagnostic testing for the novel coronavirus JAMA 323 120-134
[4]  
Rojas DP(2021)Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis PLoS One 16 589-135
[5]  
Clark J(2021)Update on SARS-CoV-2 seroprevalence: regional and worldwide Clin Microbiol Infect 27 124-495
[6]  
McLaws ML(2021)Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis J Hosp Infect 108 489-1472
[7]  
Alene M(2022)Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico Nat Commun 13 1458-1548
[8]  
Yismaw L(2022)Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study Scand J Public Health 50 1529-381
[9]  
Assemie MA(2021)Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave J Epidemiol Community Health 75 377-20
[10]  
Ketema DB(2021)Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study Int J Epidemiol 50 e01828-319
12345678910